Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
about
Cysteine-scanning mutagenesis of serotonin transporter intracellular loop 2 suggests an alpha-helical conformationThe circumplex model of affect: an integrative approach to affective neuroscience, cognitive development, and psychopathologyRotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes.Experimental analyses of gene-brain-behavior relations: some notes on their applicationPharmacogenetics in drug regulation: promise, potential and pitfalls.Association between a serotonin transporter promoter polymorphism (5HTTLPR) and personality disorder traits in a community sample.Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders.Drug development and use in the elderly: search for the right dose and dosing regimen (Parts I and II).Neuroimaging, genetics and the treatment of nicotine addictionHigh-throughput genotyping of repeat polymorphism in the regulatory region of serotonin transporter gene by gel microchip electrophoresis.Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures.IFN-gamma and TNF-alpha decrease serotonin transporter function and expression in Caco2 cells.
P2860
Q28566579-4584C93E-21FD-4869-9FEB-6C44D3E689E0Q30494504-FF3E1731-9F0C-4755-9B8D-72E969202AF1Q34188761-D3A90955-ACB7-4488-A01F-95D3D5FD826EQ34500128-B8F2D3FF-7D1B-450F-BFC4-EAEF35D15E3DQ35038052-3E77A60A-2BB9-4071-A70E-2FC2C2795E33Q35083877-7CC2E0C1-7A79-4C57-9AA5-1EA3D3833669Q35596567-A8474016-CE5E-41BA-98D2-34E7DA0BD883Q35826495-6483DC4E-EF8C-4C82-B15C-E298B1859FC9Q37010016-7489393D-9A0A-4899-8282-BF11E337F8B6Q43793724-F661AC39-1AD1-46A5-B988-BBA0A24744F5Q50734440-596698D4-0305-47BE-AE03-248D6A1E136FQ51093833-BC366BCE-19A8-43EF-9362-E7C482C00B70
P2860
Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Serotonin transporter polymorp ...... disorders and substance abuse.
@ast
Serotonin transporter polymorp ...... disorders and substance abuse.
@en
Serotonin transporter polymorp ...... disorders and substance abuse.
@nl
type
label
Serotonin transporter polymorp ...... disorders and substance abuse.
@ast
Serotonin transporter polymorp ...... disorders and substance abuse.
@en
Serotonin transporter polymorp ...... disorders and substance abuse.
@nl
prefLabel
Serotonin transporter polymorp ...... disorders and substance abuse.
@ast
Serotonin transporter polymorp ...... disorders and substance abuse.
@en
Serotonin transporter polymorp ...... disorders and substance abuse.
@nl
P2860
P356
P1433
P1476
Serotonin transporter polymorp ...... disorders and substance abuse.
@en
P2093
P2860
P304
P356
10.1517/14622416.1.3.335
P577
2000-08-01T00:00:00Z